Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Neoplasms

abstract

  • Given the lack of pharmacokinetic interaction and potential efficacy of trabectedin and gemcitabine combination therapy, further study is warranted with alternate schedules.

publication date

  • December 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3556988

Digital Object Identifier (DOI)

  • 10.1007/s00280-008-0733-7

PubMed ID

  • 18379785

Additional Document Info

start page

  • 181

end page

  • 8

volume

  • 63

number

  • 1